NEPH
Nephros Inc
NASDAQ: NEPH · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$4.47
-1.11% today
Updated 2026-09-11
Market cap
$44.09M
P/E ratio
25.38
P/S ratio
2.13x
EPS (TTM)
$0.16
Dividend yield
—
52W range
$3 – $6
Volume
0.0M
Nephros Inc (NEPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.47
12-Month target
$2.31
2030 Target
—
Intrinsic (DCF)
$4.62
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 8.38%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.